Low energy laser light (632.8 nm) suppresses amyloid-β peptide-induced oxidative and inflammatory responses in astrocytes by Yang, Xiaoguang et al.
Low energy laser light (632.8 nm) suppresses amyloid-β peptide-induced 
oxidative and inflammatory responses in astrocytes 
Xiaoguang Yang,a Sholpan Askarova,a Wenwen Sheng,b,c JK Chen,d Albert Y. Sun,e Grace Y. Sun,b,c Gang 
Yao,aand James C-M. Leea,* 
author manuscript 
The publisher's final edited version of this article is available at Neuroscience 
See other articles in PMC that cite the published article. 
Abstract 
Go to: 
INTRODUCTION 
Oxidative stress and inflammation have been implicated in many neurodegenerative diseases 
including AD (Behl et al., 1994, Simonian and Coyle, 1996, Behl and Holsboer, 1998, Heneka 
and O'Banion, 2007). Oxidative stress induced by overproduction of reactive oxygen species 
(ROS) causes damage of basic components in cells, such as lipids (Cini and Moretti, 1995), 
DNA (Mecocci et al., 1994) and proteins (Smith et al., 1991). In most cell systems, NADPH 
oxidase (Abramov et al., 2004) and mitochondrial abnormalities (Hirai et al., 2001) are two 
important sources of ROS. NADPH oxidase is comprised of six subunits (Groemping and 
Rittinger, 2005, Mizrahi et al., 2006) and its activation is mediated by translocation of the 
cytosolic subunits (p47phox, p67phox, p40phox and the GTPase Rac) to the plasma membrane subunits 
(gp91phox and p22phox) (Groemping and Rittinger, 2005, Mizrahi et al., 2006). Activation of 
NADPH oxidase in astrocytes and microglia results in increased production of superoxide 
anions, which are toxic to neighboring neurons in AD brains (Shimohama et al., 2000, Qin et al., 
2002,Abramov et al., 2004). Oxidative stress also triggers critical downstream pathways 
including activation of cPLA2, an enzyme responsible for membrane integrity (You et al., 
2005, Huber et al., 2006, Sun et al., 2007, Shelat et al., 2008). Consistent with this line of 
evidence, we have reported that Aβ activates NADPH oxidase to induce ROS and activation of 
cPLA2 in primary rat astrocytes (Zhu et al., 2006). Activated cPLA2, in turn, targets 
mitochondria, resulting in mitochondrial dysfunction and further overproduction of ROS (Zhu et 
al., 2006). Based on these previous studies, it is reasonable to suggest two major mechanisms for 
Aβ to induce ROS production, initially from NADPH oxidase and subsequently from 
mitochondria through cPLA2 activation. 
There is compelling evidence that inflammation plays a vital role in pathogenesis of AD (Heneka 
and O'Banion, 2007). Aβ triggers expressions of inflammatory factors including IL-1β and iNOS 
in glial cells (Akama and Van Eldik, 2000, White et al., 2005). IL-1β is a critical inflammatory 
cytokine in AD (Griffin and Mrak, 2002) since it can stimulate production of iNOS and other 
inflammatory cytokines (Lee et al., 1993, Blom et al., 1997). 
Low-level laser has been reported to attenuate oxidative stress and inflammation (Karageuzyan 
et al., 1998,Sakurai et al., 2000, Freitas et al., 2001, Fillipin et al., 2005, Abdel et al., 2007, Lim 
et al., 2007, Aimbire et al., 2008, Boschi et al., 2008, Hammer et al., 2008, Giuliani et al., 2009). 
Although the mechanism is yet to be fully understood, this type of light therapy has been used to 
help tissue repair and wound healing in in vivo models (Whelan et al., 2001, Whelan et al., 
2003, Albertini et al., 2007, Correa et al., 2007, Viegas et al., 2007, Aimbire et al., 2008, Reis et 
al., 2008) and rescue neurons from neurotoxic injuries (Wong-Riley et al., 2005, Liang et al., 
2006), implying a variety of promising clinical applications. In this study, we hypothesize that 
laser has the capability of suppressing Aβ-induced oxidative stress and inflammation in 
astrocytes, the most abundant cell type in the brain. We tested the effects of low-level laser light 
at 632.8 nm on Aβ-induced ROS production through the activation of NADPH oxidase, and its 
downstream pathways involving phosphorylation of cPLA2 and expression of inflammatory 
factors including IL-1β and iNOS. Information derived from this study should prove to provide 
groundwork for further investigations on the potential application of laser therapy as a treatment 
for AD. 
 
EXPERIMENAL PROCEDURES 
Chemicals and Reagents 
Dulbecco's modified Eagle's medium (DMEM) with high glucose, Ham's F-12 medium, fetal 
bovine serum (FBS), dihydroethidium (DHE) and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) were from Invitrogen (Carlsbad, CA). Bovine serum 
albumin (BSA), dimethyl sulfoxide (DMSO), hexafluoro-2-propanol (HFIP) and poly-D-lysine 
were from Sigma-Aldrich (St. Louis, MO). Aβ1–42 was from American Peptide (Sunnyvale, CA). 
gp91 ds-tat Peptide 2, a peptide inhibitor of NADPH oxidase, was from anaSpec (Fremont, CA). 
Goat polyclonal anti-gp91phox and rabbit polyclonal anti-p47phox were from Santa Cruz 
Biotechnology (Santa Cruz, CA). Fluorescein-donkey anti-goat antibody, and Texas Red-sheep 
anti-rabbit antibody were from Abcam (Cambridge, MA). 
Cell culture 
Primary cortical astrocytes were obtained using a standard stratification/cell-shaking procedure 
from newborn rat brains. Following the procedure from our previous studies yielded confluent 
mixed glial cultures within 7–9 days, after which the flasks were shaken at 180 rev./min at room 
temperature (25°C) for 3h to remove microglial cells (Zhu et al., 2005, Zhu et al., 2006). The 
purity of these primary rat astrocyte cultures was >95% verified by anti-glial fibrillary acidic 
protein labeling (data not shown). Astrocytes were cultured onto 35mm dishes or coverslips 
coated with poly-D-lysine (0.4mg/ml) and fed every 48 h with fresh DMEM culture medium 
supplemented with 10% FBS. Cells were maintained at 37°C in a 5% CO2 humidified incubator. 
Preparation of Aβ1–42 
Aβ1–42 (1mg) in the powder form was dissolved in 200μl of HFIP, and the solution was aliquoted 
into Eppendorf tubes, and after removing HFIP using a speed vacuum apparatus, samples were 
stored at −20°C until use. The Aβ film left in the tube was resuspended in 2μl DMSO and further 
diluted in 98 μl Ham's F-12 medium to make a 100μM Aβ1–42 solution. The solution was then 
sonicated for 1 min and further diluted in DMEM to the final concentration of 5μM for 
treatments. 
Laser irradiation protocol and Aβ treatment 
The source of light for irradiation was a helium-neon laser (λ=632.8 nm) with an output power of 
15mW. The light source was placed outside of incubator and an optical fiber was used to guide 
the laser from above onto a 35 mm dish covered with a plastic lid inside the incubator (Fig. 1A). 
Coverslips coated with poly-D-lysine were in 35 mm dishes if immunostaining was needed for 
confocal microscopy. The spot size was adjusted to cover the whole dish with area of 10 cm2. 
The irradiation power density was 1.5mW/cm2. In this study, the irradiation time was 3 h. The 
total energy was 162 J and energy density was 16.2 J/cm2. Both cell morphology and trypan blue 
exclusion assay showed that laser irradiation did not cause any ill-effect to cell viability (data not 
shown). In addition, no detectable change in culture medium temperature was observed during 
laser irradiation. 
 
Fig. 1 
Laser irradiation set-up and protocol 
Fig. 1B describes the laser irradiation protocol. Briefly, for the group with laser pretreatment and 
Aβ treatment, astrocytes in 35mm dishes and DMEM with phenol red and 10% FBS were 
pretreated with laser for 3 h. After allowing cells to rest for another 4 h, cells were serum starved 
for 4 h by replacing DMEM containing 10% FBS with serum-free DMEM. Cells were then 
incubated with Aβ (5μM) for 2 h for measuring phosphorylation of cPLA2, superoxide anion 
production, and colocalization between p47phoxand gp91phox, and for 16 h for measuring IL-1β and 
iNOS. For control group, astrocytes were starved for 4 h and incubated in serum-free DMEM. 
For the group with Aβ treatment alone, astrocytes were starved for 4 h and then incubated with 
Aβ in a CO2-incubator without laser installed. For the group with treatment with NADPH 
oxidase inhibitor (gp91 ds-tat Peptide 2), the inhibitor (1μM) was added into culture medium 1 h 
before Aβ treatment. 
Reactive oxygen species measurement 
To quantify superoxide anion production induced by Aβ in astrocytes, cells were starved for 4 h, 
followed by incubation of cells with both Aβ (5μM) and DHE (20μM) for 2 h. DHE is a cell 
permeable fluorescent probe. Upon oxidation by superoxide anion, it binds to DNA in nuclei and 
becomes highly fluorescent (Chapman et al., 2005). Fluorescent intensity measurement of DHE 
was performed at room temperature using a Nikon TE-2000 U fluorescence microscope with a 
20X objective lens. Images were acquired using a CCD camera controlled by a computer running 
MetaVue imaging software (Universal Imaging, PA). The fluorescent intensity of DHE per cell 
was measured. Background subtraction was done for all images prior to data analysis. 
Confocal immunofluorescence microscopy 
After treatments, cells were fixed with 4% paraformaldehyde at 37°C for 30 min. PBS 
containing 5% BSA was then applied to cells for 1 h to block nonspecific bindings. To label 
gp91phox at the cell surface, goat polyclonal anti-gp91phox (1:200 dilution) was added and 
incubated at 4°C without permeabilization. To label p47phox, cells were then permeabilized with 
0.1% Triton X-100 in PBS for 5 min. Rabbit polyclonal anti-p47phox (1:200 dilution) in PBS with 
1% BSA was then added and incubated at 4°C overnight. This was followed by fluorescent 
labeling with secondary antibodies (1:500 dilution) at room temperature for 1 h. The secondary 
antibodies for gp91phox and p47phox were fluorescein-donkey anti-goat antibody, and Texas Red-
sheep anti-rabbit antibody, respectively. Secondary antibodies did not show immunostaining in 
the absence of the primary antibody (data not shown). Confocal immunofluorescence 
microscopy was performed with an Olympus FV1000 confocal inverted microscope (Tokyo, 
Japan). Confocal images were acquired with a 60X, numerical aperture 1.2 oil immersion 
objective lens for colocalization studies between NADPH oxidase subunits, gp91phox and p47phox. 
Background subtraction was done for all images before analysis. Colocalization images were 
obtained by suppressing all colors, except yellow, in superimposed images using Adobe 
Photoshop (Adobe Systems, San Jose, CA). The colocalization of p47phox with gp91phox was 
quantified by normalizing the intensity of yellow by the intensity of gp91phox. 
Western blot analysis 
After treatments, the total protein concentration of cell lysate was determined by BCA 
(bicinchoninic acid) protein assay kit (Pierce Biotechnology, Rockford, IL) according to 
manufacture's instruction. Equivalent amounts of protein from each sample (e.g., 40 μg) were 
diluted with Laemmli buffer, boiled for 5 min, subjected to electrophoresis in 7.5% SDS-
polyacrylamide gels, and transferred to nitrocellulose membranes. Membranes were blocked for 
1 h with 5% (w/v) nonfat dry milk in Tris-buffered saline containing 0.1% (v/v) Tween 20 
(TBST) and were incubated overnight at 4°C in 3% (w/v) BSA with 0.02% (w/v) sodium azide 
in TBST with p-cPLA2 or cPLA2 antibodies (1:1000 dilution; Cell Signaling Technology, 
Beverly, MA), anti-IL-1β antibody (1:1000 dilution; R&D Systems, Minneapolis, MN), anti-
iNOS antibody (1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) and β-actin 
antibody (Sigma, St. Louis, MO). Membranes were washed three times during a 15-min period 
with TBST and incubated with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit 
IgG antibody (1: 5000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) in 5% (w/v) nonfat 
dry milk in TBST at room temperature for 1 h. After washing with TBST for three times, the 
membrane was subjected to SuperSignal West Pico Chemiluminescent detection reagents from 
Pierce (Rockford, IL) to visualize bands. The protein bands detected on x-ray film were 
quantified using a computer-driven scanner and Quantity One software (Bio-Rad, Hercules, CA). 
Statistical analysis 
Data were presented as mean ± SD from at least three independent experiments. Analysis was 
carried out with one-way ANOVA, followed by Bonferroni's post hoc tests. Values of p< 0.05 
are considered to be statistically significant. 
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RESULTS 
Laser light suppressed Aβ-induced superoxide production in primary astrocytes 
In order to investigate the effects of laser light on Aβ-induced superoxide production, primary rat 
cortical astrocytes were fluorescently labeled with DHE. We found that stimulation of astrocytes 
by Aβ for 2 h led to an increase in superoxide anions, as indicated by a significant increase in 
DHE fluorescent intensity, whereas pretreatment of cells with laser abrogated an Aβ-mediated 
increase in superoxide anions (Fig. 2). Astrocytes exposed to laser without Aβ treatment showed 
no effect on DHE intensity (Fig. 2). To verify this technique of measurement for superoxide 
anions, we demonstrated that NADPH oxidase inhibitor (gp91 ds-tat Peptide 2) suppressed Aβ-
mediated increase in DHE intensity. The inhibitor alone had no effect on DHE intensity. In sum, 
Aβ-induced ROS production in astrocytes through NADPH oxidase activation was suppressed 
by laser irradiation. 
 
Fig. 2 
Laser (632.8nm) suppressed Aβ-induced ROS production in astrocytes 
Laser light suppressed Aβ-induced assembly of NADPH oxidase subunits in primary 
astrocytes 
Since ROS production through NADPH oxidase is preceded by translocation of cytosolic 
subunits to bind with membrane subunits, we tested the effects of laser on colocalization 
between cytosolic p47phox and membrane-associated gp91phox after treating astrocytes with Aβ. 
Confocal immunofluorescence microscopy of gp91phox and p47phox subunits showed that 
stimulation of astrocytes by Aβ for 2 h led to a significant increase in colocalization between 
these two subunits, while laser pretreatment suppressed the colocalization to the control level 
(Fig. 3). These results suggest that laser attenuates Aβ-induced NADPH oxidase activation by 
inhibiting the assembly of its subunits. Astrocytes exposed to laser without Aβ treatment showed 
no effect on colocalization (Fig. 3). To validate the fluorescent confocal microscopy method for 
measurement of the colocalization between these two subunits, we demonstrated that NADPH 
oxidase inhibitor (gp91 ds-tat Peptide 2) suppressed Aβ-mediated increase in colocalization (Fig. 
3). The inhibitor alone had no effect on the colocalization. These data suggest that laser 
attenuates Aβ-induced ROS production through inhibiting NADPH oxidase activation. 
 
Fig. 3 
Laser (632.8nm) suppressed Aβ-induced colocalization between NADPH oxidase subunits 
gp91
phox
 and p47
phox
 in astrocytes 
To rule out the possibility that laser and Aβ might have affected the expressions of p47phox and 
gp91phox, which may also cause changes in the colocalization between p47phox and gp91phox, 
Western blot analysis showed that laser and Aβ treatments did not change the total expressions 
of p47phox and gp91phox in astrocytes (Fig. 4). 
 
Fig. 4 
Laser (632.8nm) and Aβ did not alter the expression of p47
phox
and gp91
phox
 in astrocytes 
Laser suppressed Aβ-induced phosphorylation of cPLA2 in primary astrocytes 
ROS from NADPH oxidase can stimulate downstream signaling pathways including activation 
of MAPK which further leads to phosphorylation of cPLA2 (Shelat et al., 2008). p-cPLA2 targets 
mitochondria and triggers further ROS production from mitochondria (Zhu et al., 2006). Since 
our data suggested that laser suppressed Aβ-induced ROS production through inhibiting NADPH 
oxidase activation, we hypothesized that laser also suppresses Aβ-induced phosphorylation of 
cPLA2. In support of our hypothesis, Western blot analysis of p-cPLA2 and cPLA2 showed that 
stimulation of astrocytes by Aβ for 30 min led to a significant increase in phosphorylation of 
cPLA2, while laser pretreatment suppressed the phosphorylation to the control level (Fig. 5). 
Astrocytes exposed to laser without Aβ treatment exerted no effect on phosphorylation of 
cPLA2 (Fig. 5). 
 
Fig. 5 
Laser (632.8nm) suppressed Aβ-induced phosphorylation of cPLA2 in astrocytes 
Laser suppressed Aβ-induced expression of pro-inflammatory factors in primary astrocytes 
AD is associated with increased inflammatory responses (Griffin et al., 1998), such as increase in 
IL-1β (Zhu and Qian, 2006). Since there is evidence that low-level light can offer anti-
inflammatory effects (Sakurai et al., 2000, Freitas et al., 2001, Lim et al., 2007, Aimbire et al., 
2008, Boschi et al., 2008,Hammer et al., 2008), we tested whether laser was capable of 
suppressing Aβ-induced inflammation in astrocytes. Western blot analyses of IL-1β and iNOS 
showed that stimulation of astrocytes by Aβ for 16 h led to a significant increase in the 
expressions of IL-1β and iNOS, while laser pretreatment suppressed the expressions to the 
control level (Fig. 6). Astrocytes exposed to laser without Aβ treatment showed that laser itself 
had no effect on expressions of these inflammatory factors (Fig. 6). 
 
Fig. 6 
Laser (632.8nm) suppressed Aβ-induced expressions of IL-1β and iNOS in astrocytes 
Go to: 
DISCUSSION 
The present study demonstrated, for the first time, the ability of laser light at λ = 632.8 nm to 
suppress Aβ-induced ROS production and inflammatory response in primary rat astrocytes. 
Specifically, we demonstrated the ability of this laser to suppress Aβ-induced ROS production, 
colocalization between NADPH oxidase subunits gp91phox and p47phox, phosphorylation of cPLA2, 
and expression of pro-inflammatory factors including IL-1β and iNOS. 
AD is a prominent neurodegenerative disease affecting a large proportion of the aging population 
(Hebert et al., 2003). Although oxidative stress has been implicated in the progression of this 
disease, the mechanism for production of ROS has not been clearly elucidated (Gupta et al., 
1991, Smith et al., 1991,Behl et al., 1994, Mecocci et al., 1994, Yan et al., 1994, Cini and 
Moretti, 1995, Forster et al., 1996,Simonian and Coyle, 1996, Smith et al., 1996, Mecocci et al., 
1997, Behl and Holsboer, 1998, Schippling et al., 2000, Hamilton et al., 2001, Lovell and 
Markesbery, 2007). Our previous studies have shown that Aβ triggered NADPH oxidase 
activation to induce ROS and subsequently phosphorylated cPLA2 in primary astrocytes (Zhu et 
al., 2006). Furthermore, cPLA2 was shown to cause a decrease in mitochondrial membrane 
potential (ΔΨm) and result in more ROS production (Zhu et al., 2006). Interestingly, low-level 
laser (λ=635nm) has been reported to increase ΔΨm and ATP synthesis (Bortoletto et al., 2004). 
Another study showed that low-level infrared laser protected PC12 cells against oxidative stress 
through its ability to modulate ΔΨm (Giuliani et al., 2009). In fact, low-level laser therapy has 
been reported to prevent oxidative stress in rat traumatized Achilles tendon (Fillipin et al., 2005) 
and Duchenne muscular dystrophy patients (Abdel et al., 2007). Our data showed that 632.8 nm 
laser suppressed Aβ-induced ROS production (Fig. 1) through inhibiting colocalization of 
NADPH oxidase subunits, gp91phox and p47phox (Fig. 2). It is known that the interactions of 
gp91phox with the cytosolic components result in a conformational change in gp91phox, which 
enables the electron flow from NADPH to oxygen and the generation of superoxide anions (Han 
et al., 1998, Diebold and Bokoch, 2001). In this study, our results lead to a new hypothesis that 
low-energy laser light may be capable of causing a conformation change in gp91phox, which 
inhibits the interaction of gp91phox with the cytosolic components and the generation of 
superoxide anions. More investigations are needed to further our understanding in the 
mechanism of inhibiting the assembling of gp91phox with the cytosolic components by low-energy 
laser light. Consistent with previous studies reporting that phosphorylation of cPLA2 is one of the 
downstream pathways of NADPH oxidase (Zhu et al., 2006, Shelat et al., 2008), our data also 
showed that Aβ-induced p-cPLA2 was suppressed by laser pretreatment (Fig. 3). Since cPLA2 is 
associated with perturbation of mitochondria ΔΨm, results from this study suggested that laser 
pretreatment reduced ROS from NADPH oxidase and subsequently ROS-induced mitochondrial 
dysfunction through cPLA2. 
Inflammation is an early event of AD and plays critical roles in disease development (Tuppo and 
Arias, 2005, Wyss-Coray, 2006, Cameron and Landreth, 2010, McNaull et al., 2010). The major 
players involved in the inflammatory process in AD are microglia and astrocytes (McGeer and 
McGeer, 1995, 2001, Combs, 2009). In AD, Aβ plaques are surrounded by activated microglia 
and astrocytes (Wallace et al., 1997, Yin et al., 2006, Bolmont et al., 2008, Koenigsknecht-
Talboo et al., 2008, Yan et al., 2009) which have been shown to secrete many pro-inflammatory 
molecules, such as cytokines, chemokines, prostaglandins, complement proteins and complement 
inhibitors (McGeer and McGeer, 1995, 2001, Zhang et al., 2009). Among these pro-
inflammatory molecules, IL-1β is an important regulator of inflammatory cascades and plays a 
key role in AD pathogenesis (Griffin and Mrak, 2002). IL-1β is capable of stimulating astrocytes 
to produce additional pro-inflammatory cytokines such as IL-6, another inflammation marker 
associated with neurodegeneration (Blom et al., 1997, Fiebich et al., 1998, Griffin et al., 1998). 
Furthermore, IL-1β triggers activation of NFκB (Cao et al., 1996, Song et al., 1997, Baeuerle, 
1998) which is necessary for Aβ-stimulated iNOS induction in astrocytes (Akama et al., 
1998, Akama and Van Eldik, 2000). iNOS is responsible for production of nitric oxide (Lee et 
al., 1993, Weldon et al., 1997) which may be detrimental to neurons (Hu et al., 1997). Low-level 
laser attenuates inflammation (Sakurai et al., 2000, Freitas et al., 2001, Lim et al., 2007, Aimbire 
et al., 2008, Boschi et al., 2008, Hammer et al., 2008) and helps tissue repair and wound healing 
(Whelan et al., 2001, Whelan et al., 2003, Albertini et al., 2007, Correa et al., 2007, Viegas et al., 
2007, Reis et al., 2008). However, the effects of laser on Aβ-induced inflammation in astrocytes 
have not been studied. Here we showed that laser pretreatment suppressed Aβ-induced the 
expression of IL-1β in astrocytes (Fig. 4A). Consistent with the notion that Aβ stimulation of 
iNOS in astrocytes is IL-1β dependent (Akama and Van Eldik, 2000), laser also attenuated iNOS 
induction in astrocytes (Fig. 4B). Since IL-1β is a key player in AD pathogenesis and iNOS 
activity has detrimental effects on neurons, 632.8 nm laser may also protect neurons against 
inflammation in AD brain. 
Previous studies suggest that low-energy light exerts beneficial effects through modulating gene 
expressions (Shefer et al., 2002, Eells et al., 2004). Brief treatment with 670 nm light-emitting 
diode (LED) regulates expression of genes encoding DNA repair protein, antioxidant enzymes 
and molecular chaperons in retinas of methanol intoxicated rats (Eells et al., 2004). Low-energy 
laser irradiation (632.8nm, 4.5mW, 3 s) also increases the expression of anti-apoptotic protein 
Bcl-2 and reduces the expression of pro-apoptotic protein Bax in muscle cell cultures (Shefer et 
al., 2002). 
There has been a large body of compelling evidence suggesting that biological effects of lights 
could be used to treat neurodegenerative conditions, although the mechanism has yet to be fully 
understood. In vitro, LED attenuates apoptosis in PC12 cells after exposure to Aβ25–35 (Duan et 
al., 2003). LED also increases survival and ATP content of neurons and decreases oxidative 
stress after rotenone-induced toxicity (Liang et al., 2008). In fact, LED also promotes neurite 
outgrowth of rat cortex in tissue culture (Wollman and Rochkind, 1998). In vivo, near-infrared 
light exerts neuroprotective effects against rotenone-induced neurotoxicity in rats (Rojas et al., 
2008), and these effects was supported by assessing behavioral, morphological and 
neurochemical changes (Rojas et al., 2008). LED has been shown to induce central and 
peripheral nerve regeneration after trauma (Anders et al., 1993, Byrnes et al., 2005) and reduce 
neuroinflammation in rats (Byrnes et al., 2005). In this study, we demonstrated that 632.8 nm 
laser suppressed Aβ-induced ROS production and inflammation in primary astrocytes. Although 
we did not investigate the dose response by varying irradiance (W/cm2) and energy density 
(J/cm2), it is important to note that a biphasic dose response has been demonstrated many times 
in low level laser therapy research (Huang et al., 2009). These dose dependence studies applied 
irradiance ranging from 0.7 to 40 mW/cm2and energy density ranging from 0.18 to 9 J/cm2. 
While the irradiance (1.5 mW/cm2) was applied in this study, the energy density (16.2 J/cm2) was 
outside the range of those in previous studies from others. Therefore, one might consider 
optimizing the use of light by applying various irradiance, and exposure time. Another parameter 
for optimization is the wavelength, because a longer wavelength is known for a deeper tissue 
penetration. For example, 810 nm LED light enhances mitochondrial metabolism (Trimmer et 
al., 2009), and transcranial infrared laser (805 nm) therapy has been reported to improve clinical 
rating scores after embolic strokes in rabbits (Lapchak et al., 2004). This study serves as a proof-
of-principle to provide insights into potential applications of laser therapy for attenuating 
oxidative and inflammatory responses in AD. 
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Abbreviations 
AD Alzheimer's disease 
Aβ amyloid β-peptide 
BCA bicinchoninic acid 
BSA Bovine serum albumin 
cPLA2 cytosolic phospholipase A2 
DHE dihydroethidium 
DMEM Dulbecco's modified Eagle's medium 
DMSO dimethyl sulfoxide 
FBS fetal bovine serum 
HFIP hexafluoro-2-propanol 
IL-1β interleukin-1β 
iNOS inducible nitric-oxide synthase 
LED light-emitting diode 
ROS reactive oxygen species 
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